The Lethal Science of mRNA and Its Effects on Food and the Body

The U.S. government has invested billions of dollars into mRNA research, and Peter warns against the dangers of the Covid vaccine, especially for pregnant women. There are even rumblings that routine vaccines for cows may be replaced with mRNA shots, which could spell trouble for humans who consume beef. The infusion of mRNA into prospective food sources is a way of passively vaccinating the population, he says.

More on mRNA:

1. Structure and Function: mRNA is a single-stranded molecule that carries genetic information from DNA in the nucleus to the cytoplasm, where it serves as a template for protein synthesis. It is composed of four types of nucleotide bases: adenine (A), cytosine (C), guanine (G), and uracil (U).

2. Transcription: The process of creating mRNA from DNA is called transcription. During transcription, an enzyme called RNA polymerase reads the DNA sequence and synthesizes a complementary strand of mRNA.

3. Translation: Once mRNA is synthesized, it moves from the nucleus to the ribosome in the cytoplasm. During translation, the ribosome reads the sequence of mRNA bases and assembles amino acids to form a protein. This process involves transfer RNA (tRNA), which brings the appropriate amino acids in response to the codons (three-base sequences) on the mRNA.

4. mRNA in Biotechnology and Medicine: Recently, mRNA has gained significant attention due to its role in the development of mRNA-based vaccines, such as those for COVID-19. These vaccines use synthetic mRNA to instruct cells to produce a piece of the virus (such as the spike protein in SARS-CoV-2), triggering an immune response without causing the disease.

5. Advantages of mRNA Therapeutics: mRNA therapies have several advantages, including rapid development, the ability to tailor them to different targets, and the fact that they do not integrate into the host genome, minimizing the risk of insertional mutagenesis.

6. Stability and Delivery Challenges: mRNA is inherently unstable and can be quickly degraded in the body. Therefore, it often requires specialized delivery systems, like lipid nanoparticles, to protect it and facilitate its entry into cells.

7. Regulatory Elements: To function effectively, mRNA molecules also include regulatory sequences such as the 5' cap and the 3' poly(A) tail, which help stabilize the mRNA and enhance its translation efficiency.

8. Diverse Applications: Beyond vaccines, mRNA technology is being explored for its potential in treating genetic disorders, cancers, and as a tool in regenerative medicine:

   Possible Problems:

   1. Instability and Degradation: mRNA molecules are inherently unstable. They can be quickly degraded by enzymes in the body, which makes delivering them to the target cells without degradation a significant challenge.
   2. Storage and Transportation Requirements: mRNA-based therapies, including vaccines, often require storage at extremely low temperatures. This can complicate their distribution and storage, especially in regions with limited cold-chain logistics.
   3. Immune System Activation: mRNA can potentially activate the innate immune system, leading to unintended inflammatory responses. This requires careful design and modification of mRNA molecules to evade such immune detection while still maintaining their effectiveness.
   4. Delivery Systems: Efficient and targeted delivery of mRNA into the desired cells is crucial. This often necessitates the use of specialized delivery systems, like lipid nanoparticles, which themselves can pose challenges in terms of biocompatibility and potential side effects.
   5. Limited Duration of Effectiveness: The transient nature of mRNA means that its effects are not permanent. While this is advantageous for some applications (like vaccination), it limits its utility in other scenarios, such as in the treatment of chronic diseases where long-term expression of the therapeutic protein is needed.
   6. Manufacturing Complexity: The production of mRNA for therapeutic purposes is a complex and costly process. It requires high levels of purity and quality control, which can increase the cost and time required for development.
   7. Limited Experience and Long-Term Data: mRNA technology, particularly for therapeutic uses other than vaccines, is relatively new. There is limited long-term data on the efficacy and safety of mRNA-based treatments, which may impact public trust and regulatory approval processes.
   8. Risk of Antibody Response Against Modified mRNA: Some modifications to mRNA are necessary to make it more stable and effective, but these modifications can sometimes lead to the development of antibodies against the modified mRNA, which might reduce its effectiveness in future applications.